🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,895.50
+2.00 (0.11%)
Nov 20, 2026, 9:04 AM JST

Sumitomo Pharma Statistics

Total Valuation

Sumitomo Pharma has a market cap or net worth of JPY 850.31 billion. The enterprise value is 912.24 billion.

Market Cap850.31B
Enterprise Value 912.24B

Important Dates

The last earnings date was Friday, October 30, 2026.

Earnings Date Oct 30, 2026
Ex-Dividend Date Mar 30, 2027

Share Statistics

Sumitomo Pharma has 448.59 million shares outstanding. The number of shares has increased by 5.65% in one year.

Current Share Class 448.59M
Shares Outstanding 448.59M
Shares Change (YoY) +5.65%
Shares Change (QoQ) +2.99%
Owned by Insiders (%) 0.03%
Owned by Institutions (%) 21.88%
Float 238.43M

Valuation Ratios

The trailing PE ratio is 17.20 and the forward PE ratio is 9.20.

PE Ratio 17.20
Forward PE 9.20
PS Ratio 1.73
PB Ratio 1.97
P/TBV Ratio 12.25
P/FCF Ratio 12.59
P/OCF Ratio 12.08
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 46.47, with an EV/FCF ratio of 13.51.

EV / Earnings 19.73
EV / Sales 1.85
EV / EBITDA 46.47
EV / EBIT n/a
EV / FCF 13.51

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.32.

Current Ratio 1.36
Quick Ratio 0.93
Debt / Equity 0.32
Debt / EBITDA 8.39
Debt / FCF 2.07
Interest Coverage -0.34

Financial Efficiency

Return on equity (ROE) is 13.28% and return on invested capital (ROIC) is -0.35%.

Return on Equity (ROE) 13.28%
Return on Assets (ROA) -0.14%
Return on Invested Capital (ROIC) -0.35%
Return on Capital Employed (ROCE) -0.29%
Weighted Average Cost of Capital (WACC) 6.17%
Revenue Per Employee 128.57M
Profits Per Employee 12.07M
Employee Count4,980
Asset Turnover 0.60
Inventory Turnover 2.66

Taxes

In the past 12 months, Sumitomo Pharma has paid 681.00 million in taxes.

Income Tax 681.00M
Effective Tax Rate 1.45%

Stock Price Statistics

The stock price has decreased by -22.70% in the last 52 weeks. The beta is 0.42, so Sumitomo Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.42
52-Week Price Change -22.70%
50-Day Moving Average 1,756.75
200-Day Moving Average 1,756.35
Relative Strength Index (RSI) 51.26
Average Volume (20 Days) 4,286,145

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sumitomo Pharma had revenue of JPY 492.66 billion and earned 46.24 billion in profits. Earnings per share was 110.18.

Revenue492.66B
Gross Profit 262.44B
Operating Income -1.77B
Pretax Income 46.92B
Net Income 46.24B
EBITDA 16.66B
EBIT -1.77B
Earnings Per Share (EPS) 110.18
Full Income Statement

Balance Sheet

The company has 77.76 billion in cash and 139.69 billion in debt, with a net cash position of -61.93 billion or -138.06 per share.

Cash & Cash Equivalents 77.76B
Total Debt 139.69B
Net Cash -61.93B
Net Cash Per Share -138.06
Equity (Book Value) 431.11B
Book Value Per Share 961.02
Working Capital 89.44B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 70.36 billion and capital expenditures -2.83 billion, giving a free cash flow of 67.54 billion.

Operating Cash Flow 70.36B
Capital Expenditures -2.83B
Depreciation & Amortization 18.42B
Net Borrowing -126.54B
Free Cash Flow 67.54B
FCF Per Share 150.55
Full Cash Flow Statement

Margins

Gross margin is 53.27%, with operating and profit margins of -0.36% and 9.39%.

Gross Margin 53.27%
Operating Margin -0.36%
Pretax Margin 9.52%
Profit Margin 9.39%
EBITDA Margin 3.38%
EBIT Margin -0.36%
FCF Margin 13.71%

Dividends & Yields

This stock pays an annual dividend of 15.00, which amounts to a dividend yield of 0.79%.

Dividend Per Share 15.00
Dividend Yield 0.79%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 0.00%
FCF Payout Ratio 9.96%
Buyback Yield -5.65%
Shareholder Yield -4.85%
Earnings Yield 5.81%
FCF Yield 7.94%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Analyst Forecast

The average price target for Sumitomo Pharma is 2,242.86, which is 18.33% higher than the current price. The consensus rating is "Buy".

Price Target 2,242.86
Price Target Difference 18.33%
Analyst Consensus Buy
Analyst Count 7
Revenue Growth Forecast (3Y) 10.93%
EPS Growth Forecast (3Y) -14.02%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Sumitomo Pharma has an Altman Z-Score of 2.15 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 2.15
Piotroski F-Score 5